The Effect of Paricalcitol on Vascular Calcification and Cardiovascular Disease in Uremia: Beyond PTH Control
Secondary hyperparathyroidism is a systemic disorder that associates with bone and cardiovascular disease, including arterial calcification. Treatment with calcitriol, the active form of vitamin D, reduces parathyroid hormone levels, but may result in elevations in serum calcium and phosphorus, incr...
Saved in:
Main Authors: | Mario Cozzolino, Florjan Mehmeti, Paola Ciceri, Elisa Volpi, Andrea Stucchi, Irene Brenna, Daniele Cusi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | International Journal of Nephrology |
Online Access: | http://dx.doi.org/10.4061/2011/269060 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sinomenine attenuates uremia vascular calcification by miR-143-5p
by: Fengyi Yu, et al.
Published: (2025-01-01) -
Role of Paricalcitol in Modulating the Immune Response in Patients with Renal Disease
by: Silvia Lucisano, et al.
Published: (2015-01-01) -
Biomarkers of Chronic Inflammatory State in Uremia and Cardiovascular Disease
by: Vincenzo Panichi, et al.
Published: (2012-01-01) -
Pathophysiological and Genetic Aspects of Vascular Calcification
by: Luis Fernando Escobar Guzman, et al.
Published: (2020-01-01) -
Epidemiological Research Advances in Vascular Calcification in Diabetes
by: Haipeng Yao, et al.
Published: (2021-01-01)